Connexins are subunits of gap junction channels, which mediate the direct transfer of ions, second messenger molecules and other metabolites between contacting cells. Gap junctions are thought to be involved in tissue homeostasis, embryonic development and the control of cell proliferation [1,2]. It has also been suggested that the loss of intercellular communication via gap junctions may contribute to multistage carcinogenesis [3-5]. We have previously shown that transgenic mice that lack connexin32 (Cx32), the major gap junction protein expressed in hepatocytes, express lower levels of a second hepatic gap junction protein, Cx26, suggesting that Cx32 has a stabilizing effect on Cx26 [6]. Here, we report that male and female one-year-old mice deficient for Cx32 had 25-fold more and 8-fold more spontaneous liver tumors than wild-type mice, respectively. Incorporation of bromodeoxyuridine (BrdU) into the liver was higher for Cx32-deficient mice than for wild-type mice, suggesting that their hepatocyte proliferation rate was higher. Furthermore, intraperitoneal injection, two weeks after birth, of the carcinogen diethylnitrosamine (DEN) led, after one year, both to more liver tumors in Cx32-deficient mice than in controls, and to accelerated tumor growth. Loss of Cx32 protein from hepatic gap junctions is therefore likely to cause enhanced clonal survival and expansion of mutated ('initiated') cells, which results in a higher susceptibility to hepatic tumors. Our results demonstrate that functional gap junctions inhibit the development of spontaneous and chemically induced tumors in mouse liver.
ratio of liver weight to body weight was very similar for Cx32-deficient and wild-type mice (see supplementary material). Nuclear labelling indices (LI) showed a 13.7-fold higher incorporation of BrdU into hepatocytes of female Cx32-deficient mice (LI: 0.110 ± 0.061%), and a 3.8-fold higher incorporation into hepatocytes of male Cx32-deficient mice (LI: 0.024 ± 0.006%), than into the corresponding female (LI: 0.008 ± 0.005%; p < 0.05) and male (LI: 0.006 ± 0.003%; p < 0.05) wild-type hepatocytes. Additional analysis of the BrdU-labelled wild-type and Cx32-deficient nuclei revealed no significant polyploidization, as estimated by the average diameter of nuclei (data not shown). As no increase was observed in either the polyploidization of hepatocytes or the average weight of livers from Cx32-deficient mice, and since strain-specific differences in the DNA precursor pool size between mutant and wild-type mice are unlikely, our data suggest a higher cell turnover in Cx32-deficient liver. This increased cell turnover, which is larger in females than in males (presumably as a result of the action of sex hormones) could lead to aberrant cell proliferation and, therefore, to a higher probability of cells surviving tumor initiation.
After 12 months, Cx32-deficient male and female mice had 25-fold more and 8-fold more spontaneous tumors per liver than control mice, respectively. After 6 months, macroscopically visible lesions were already detectable in male Cx32-deficient mice, whereas the first tumors visible in female Cx32-deficient mice, as well as male and female wild-type mice, were present after 12 months (Table 1) . Intraperitoneal injection of DEN into 15-day-old mice led, after 6 months, to a large increase in liver weight due to massive tumor growth in Cx32-deficient mice, compared to control mice ( Figure 1a) . DEN induces liver specific tumors as it is metabolically activated in hepatocytes by abundant cytochrome P-450 isoenzymes leading to alkylation of purine residues in DNA [7] .
When we analyzed various organs other than liver that express Cx32, such as pancreas, macroscopically visible tumors were not detected. After 9 months, three-fold and five-fold more macroscopically visible tumors were counted in the livers of Cx32-deficient male and female mice than in control animals, respectively (Figure 1b) . DEN-induced liver tumors appeared 3 months earlier in male than in female mice, consistent with the known effects of sex hormones on hepatocarcinogenesis in mice [8] . Stereological analysis revealed that the fraction of liver occupied by lesions deficient for the marker enzyme glucose 6-phosphatase (G6Pase) was, on average, 62-fold higher in Cx32-deficient male and female mice than in wild-type animals ( Figure 1c ). The number of lesions deficient for G6Pase, however, was only two-fold to threefold higher in Cx32-deficient mice, suggesting that the Cx32 defect affected the proliferation of G6Pase-deficient cells more than their initiation by the carcinogen. This enhanced proliferation was clearly shown by the preferential shift with increasing time to larger diameters of DENinduced neoplastic areas in Cx32-deficient mice compared to those in wild-type mice (see supplementary material).
Mice deficient for the Cx32 gene were generated by standard methods of targeted homologous recombination, leading to a mixed genetic background of C57BL/6 and 129Sv inbred strains [6] . In order to expand the population of Cx32-mutant mice, mice heterozygous for the Cx32 mutation were initially crossed with C57BL/6 mice, such that Cx32-deficient mice have a higher C57BL/6 genetic background than the C57BL/6/129/Sv-F1 controls [6] . Although the higher C57BL/6 genetic background should have resulted in a decreased susceptibility to liver tumors [9] , the number and size of liver tumors were always found to be dramatically higher in Cx32-deficient mice. We therefore conclude that possible polymorphic differences between the genetic background of the Cx32-deficient and our wild-type controls (the F1 generation of a C57BL/6 and 129Sv cross) are unlikely to have caused the observed difference in tumorigenicity.
The parenchymal origin of the liver tumors was confirmed by northern blot hybridization, which showed that the 714 Current Biology, Vol 7 No 9 tumors contained significant levels of albumin mRNA. (Figure 2a ). The relative amount of Cx26 mRNA was the same in the tumors of Cx32-deficient mice as in corresponding control livers, whereas tumors from wild-type mice expressed, for unknown reasons, 40-50% less Cx26 mRNA than wild-type control livers (Figure 2a) . Immunofluorescence analysis of normal tissue confirmed that Cx26 expression was much lower in Cx32-deficient liver than in wild-type liver (Figure 2d ,e), as previously noted [6] . Interestingly, Cx26 protein expression was no lower in Cx32-deficient liver tumors than in the surrounding normal tissue ( Figure 2e) ; there was also no impairment of Cx32 and Cx26 protein expression in wild-type tumors (Figure 2d ,f). This contrasts with previous results using rat liver, in which a tumor-specific decrease in Cx32 expression was observed [3] .
Immunoblot analysis revealed that Cx26 protein expression in Cx32-deficient liver was about two thirds lower than in wild-type liver (Figure 2i ). Cx32 apparently stabilizes the Cx26 protein, possibly by heterotypic or heteromeric interaction when both proteins are subunits of the same gap junction channel [10] . Thus, we cannot determine whether the tumor suppressive effect of the intercellular communication mediated by gap junctions in mouse liver is due only to the Cx32 protein itself or is augmented by functional expression of the Cx26 protein. Liver tumors of male wildtype mice expressed the same levels of Cx26 and Cx32 protein as control livers of wild-type mice (Figure 2h,i) . The level of Cx26 protein expression in tumors of Cx32-deficient mice was slightly lower than in Cx32-deficient control liver (Figure 2i Table 1 ). G6Pase staining of lesions from (b) wild-type and (c) Cx32-deficient mice; note the lack of G6Pase activity in areas of neoplastic tissue. Indirect immunofluorescence using antibodies specific for (d,e) Cx26 and (f,g) Cx32 on cryostat serial sections from (d,f) wild-type and (e,g) Cx32-deficient liver. In Cx32-deficient liver, (g) Cx32 expression was absent and (e) Cx26 protein expression (arrowheads) was strongly decreased. The magnification bar isthe increased hepatocarcinogenesis in Cx32-deficient mice? We suggest that this may be primarily due to the different permeabilities of Cx32 and Cx26 channels, described in studies using several dyes [14] . Possibly, intercellular diffusion of second messenger molecules such as cyclic nucleotides or inositol 1,4,5-trisphosphate may be more efficient through Cx32 channels than Cx26 channels. Loss of Cx32 (and decreased expression of Cx26 protein) may therefore cause an imbalance in metabolic cooperation or a disturbed equilibration of second messenger molecules in the liver acinus, which could result in enhanced proliferation of cells initiated to form tumors.
Materials and methods

Treatment of animals and BrdU incorporation
Mice were kept under standard conditions and male and female offspring received on day 15 after birth a single intraperitoneal injection of DEN (Sigma; 20 µg/g body weight), diluted with phosphate buffered saline (PBS). DEN-treated and untreated Cx32-deficient mice as well as C57BL/6/129/Sv-F1 controls [6] were weighed and sacrificed at 3, 6, 9 or 12 months. Whole mice were analyzed for macroscopically visible tumors. All livers were excised, rinsed in PBS and weighed. Randomly selected liver tumors were used for preparation of RNA and protein. To assay the incorporation of BrdU, Cx32-deficient and wildtype mice (6 months old), were injected intraperitoneally with BrdU (200 µg/g body weight), 2 h and 4 h before sacrificing. The lobus sinister medialis was excised and stained for BrdU-positive nuclei, as described [15] . For polyploidization analysis, the average diameters of BrdU-labelled nuclei were measured. All data in this paper were statistically evaluated, using Wilcoxon´s rank sum test for unpaired values.
Histochemistry, quantitative evaluation of tumors and indirect immunofluorescence
For histochemical analysis, up to three sections (10 µm each) were prepared from lobus sinister lateralis frozen on dry ice. The sections were cut 200 µm apart from each other, in order to minimize double counting of enzyme-altered lesions, and stained for G6Pase activity [16] . Analysis of the volume fraction of enzyme-altered tissue in liver, as well as the number and size distribution of enzyme-altered lesions, were performed by the stereological procedure of Saltykov, as recommended [17] . The immunochemical labelling procedure for Cx32 and Cx26 protein has been described previously [18] . Primary antibodies [monoclonal anti-rat Cx32 (0.5 µg/ml) and polyclonal rabbit anti-rat Cx26 (1 µg/ml) both in 0.1% BSA] were provided by Zymed.
Preparation of RNA and northern blot analysis
Liver tumors ( > 1 mm in diameter) were excised and samples (10 µg) of total RNA were subjected to agarose gel electrophoresis, blotted onto Hybond-N membranes, hybridized to radiolabelled DNA probes [12] and autoradiographed. Signals were normalized relative to the amount of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA [19] .
Immunoblots
For protein analysis, samples were homogenized and sonificated [13] . Equal amounts of protein (50 µg) were subjected to polyacrylamide gel electrophoresis: Cx26 was separated on a 10% gel, whereas Cx32 was separated on a 12.5% gel. Transfer of proteins onto nitrocellulose and detection of Cx26 with antibodies (Zymed, 1.5 µg/ml) were performed as previously described [13] . Equal amounts of total protein and Cx32 immunoreactivity (Cx32 antibodies from Zymed, 1.5 µg/ml in 0.05 M Tris.HCl/0.15 M NaCl, pH 7.5) were monitored with the DIG Total Protein/Antigen Double Staining Kit (mouse; Boehringer Mannheim). Endogenous peroxidases or alkaline phosphatases were blocked with 0.1% (w/v) Levamisole (Sigma) or 0.05% (v/v) H 2 O 2 before incubating with antibodies. A table showing the liver weights and LI of hepatocytes and two figures showing the diameters of DEN-induced neoplasia and dye transfer among hepatocytes are published with this paper on the internet.
Supplementary material available
